IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.

The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are associated with chemoresistance, disease progression and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacological inhibitors of IAPs. The develo...

Full description

Bibliographic Details
Main Authors: Gyrd-Hansen, M, Meier, P
Format: Journal article
Language:English
Published: 2010
_version_ 1797064506891829248
author Gyrd-Hansen, M
Meier, P
author_facet Gyrd-Hansen, M
Meier, P
author_sort Gyrd-Hansen, M
collection OXFORD
description The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are associated with chemoresistance, disease progression and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacological inhibitors of IAPs. The development of such inhibitors has radically changed our knowledge of the signalling processes that are regulated by IAPs. Recent studies indicate that IAPs not only regulate caspases and apoptosis, but also modulate inflammatory signalling and immunity, mitogenic kinase signalling, proliferation and mitosis, as well as cell invasion and metastasis.
first_indexed 2024-03-06T21:15:19Z
format Journal article
id oxford-uuid:3f97b7c9-00e9-44be-8967-5a02eb03c48c
institution University of Oxford
language English
last_indexed 2024-03-06T21:15:19Z
publishDate 2010
record_format dspace
spelling oxford-uuid:3f97b7c9-00e9-44be-8967-5a02eb03c48c2022-03-26T14:32:57ZIAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3f97b7c9-00e9-44be-8967-5a02eb03c48cEnglishSymplectic Elements at Oxford2010Gyrd-Hansen, MMeier, PThe realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are associated with chemoresistance, disease progression and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacological inhibitors of IAPs. The development of such inhibitors has radically changed our knowledge of the signalling processes that are regulated by IAPs. Recent studies indicate that IAPs not only regulate caspases and apoptosis, but also modulate inflammatory signalling and immunity, mitogenic kinase signalling, proliferation and mitosis, as well as cell invasion and metastasis.
spellingShingle Gyrd-Hansen, M
Meier, P
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
title IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
title_full IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
title_fullStr IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
title_full_unstemmed IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
title_short IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
title_sort iaps from caspase inhibitors to modulators of nf kappab inflammation and cancer
work_keys_str_mv AT gyrdhansenm iapsfromcaspaseinhibitorstomodulatorsofnfkappabinflammationandcancer
AT meierp iapsfromcaspaseinhibitorstomodulatorsofnfkappabinflammationandcancer